Anjum Ahmad brings extensive insight in the UK’s life sciences sector having been the longstanding Group Finance Director of Touchstone Innovations Plc (formerly Imperial Innovations) - the AIM listed venture capital investor in early stage science.
In his former role at Touchstone he was one of the four-person senior executive team, presenting over £200m of investment opportunities in the therapeutics/biotech field to the Luxembourg Board, managing the corporate finance activity for an equity raise of £250m, responsible for the finance/treasury tax operations, conducting portfolio company asset valuations, and presenting the interim/year end results alongside their CEO. He was also responsible for their I.T. and H.R. functions.
Prior to Imperial Innovations he held finance positions within a tech start-up and GSK.